Literature DB >> 34222864

Neurological and mental health consequences of COVID-19: potential implications for well-being and labour force.

Irene Beatrix Meier1, Camila Vieira Ligo Teixeira2, Ioannis Tarnanas3, Fareed Mirza4, Lawrence Rajendran5.   

Abstract

Recent case studies show that the SARS-CoV-2 infectious disease, COVID-19, is associated with accelerated decline of mental health, in particular, cognition in elderly individuals, but also with neurological and neuropsychiatric illness in young people. Recent studies also show a bidirectional link between COVID-19 and mental health in that people with previous history of psychiatric illness have a higher risk for contracting COVID-19 and that COVID-19 patients display a variety of psychiatric illnesses. Risk factors and the response of the central nervous system to the virus show large overlaps with pathophysiological processes associated with Alzheimer's disease, delirium, post-operative cognitive dysfunction and acute disseminated encephalomyelitis, all characterized by cognitive impairment. These similarities lead to the hypothesis that the neurological symptoms could arise from neuroinflammation and immune cell dysfunction both in the periphery as well as in the central nervous system and the assumption that long-term consequences of COVID-19 may lead to cognitive impairment in the well-being of the patient and thus in today's workforce, resulting in large loss of productivity. Therefore, particular attention should be paid to neurological protection during treatment and recovery of COVID-19, while cognitive consequences may require monitoring.
© The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain.

Entities:  

Keywords:  Alzheimer’s disease; COVID-19; cognitive decline; post-operative cognitive dysfunction; production loss

Year:  2021        PMID: 34222864      PMCID: PMC7929222          DOI: 10.1093/braincomms/fcab012

Source DB:  PubMed          Journal:  Brain Commun        ISSN: 2632-1297


  40 in total

1.  Nonstroke cardiovascular disease and risk of Alzheimer disease and dementia.

Authors:  Ulrika K Eriksson; Anna M Bennet; Margaret Gatz; Paul W Dickman; Nancy L Pedersen
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Jul-Sep       Impact factor: 2.703

2.  Treatment costs and productivity losses caused by traumatic brain injuries.

Authors:  Risto Tuominen; Petteri Joelsson; Olli Tenovuo
Journal:  Brain Inj       Date:  2012       Impact factor: 2.311

3.  Complement and microglia mediate early synapse loss in Alzheimer mouse models.

Authors:  Victoria F Beja-Glasser; Bianca M Nfonoyim; Soyon Hong; Arnaud Frouin; Shaomin Li; Saranya Ramakrishnan; Katherine M Merry; Qiaoqiao Shi; Arnon Rosenthal; Ben A Barres; Cynthia A Lemere; Dennis J Selkoe; Beth Stevens
Journal:  Science       Date:  2016-03-31       Impact factor: 47.728

4.  Working memory capacity predicts individual differences in social-distancing compliance during the COVID-19 pandemic in the United States.

Authors:  Weizhen Xie; Stephen Campbell; Weiwei Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-10       Impact factor: 11.205

5.  SARS-CoV-2: A new virus but a familiar inflammation brain pattern.

Authors:  Giuseppe De Santis
Journal:  Brain Behav Immun       Date:  2020-04-27       Impact factor: 7.217

6.  The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings.

Authors:  Ross W Paterson; Rachel L Brown; Laura Benjamin; Ross Nortley; Sarah Wiethoff; Tehmina Bharucha; Dipa L Jayaseelan; Guru Kumar; Rhian E Raftopoulos; Laura Zambreanu; Vinojini Vivekanandam; Anthony Khoo; Ruth Geraldes; Krishna Chinthapalli; Elena Boyd; Hatice Tuzlali; Gary Price; Gerry Christofi; Jasper Morrow; Patricia McNamara; Benjamin McLoughlin; Soon Tjin Lim; Puja R Mehta; Viva Levee; Stephen Keddie; Wisdom Yong; S Anand Trip; Alexander J M Foulkes; Gary Hotton; Thomas D Miller; Alex D Everitt; Christopher Carswell; Nicholas W S Davies; Michael Yoong; David Attwell; Jemeen Sreedharan; Eli Silber; Jonathan M Schott; Arvind Chandratheva; Richard J Perry; Robert Simister; Anna Checkley; Nicky Longley; Simon F Farmer; Francesco Carletti; Catherine Houlihan; Maria Thom; Michael P Lunn; Jennifer Spillane; Robin Howard; Angela Vincent; David J Werring; Chandrashekar Hoskote; Hans Rolf Jäger; Hadi Manji; Michael S Zandi
Journal:  Brain       Date:  2020-10-01       Impact factor: 13.501

Review 7.  The role of APP and BACE1 trafficking in APP processing and amyloid-β generation.

Authors:  Xiaojie Zhang; Weihong Song
Journal:  Alzheimers Res Ther       Date:  2013-10-08       Impact factor: 6.982

8.  COVID-19: consider cytokine storm syndromes and immunosuppression.

Authors:  Puja Mehta; Daniel F McAuley; Michael Brown; Emilie Sanchez; Rachel S Tattersall; Jessica J Manson
Journal:  Lancet       Date:  2020-03-16       Impact factor: 79.321

9.  Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study.

Authors:  Seung Won Lee; Jee Myung Yang; Sung Yong Moon; In Kyung Yoo; Eun Kyo Ha; So Young Kim; Un Min Park; Sejin Choi; Sang-Hyuk Lee; Yong Min Ahn; Jae-Min Kim; Hyun Yong Koh; Dong Keon Yon
Journal:  Lancet Psychiatry       Date:  2020-09-17       Impact factor: 27.083

10.  Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses.

Authors:  Michael Letko; Andrea Marzi; Vincent Munster
Journal:  Nat Microbiol       Date:  2020-02-24       Impact factor: 17.745

View more
  3 in total

1.  COVID-19-related psychiatric manifestations requiring hospitalization: Analysis in older vs. younger patients.

Authors:  Fabiola Sârbu; Violeta Diana Oprea; Alin Laurențiu Tatu; Eduard Polea Drima; Cristina Ștefănescu; Aurel Nechita; Gelu Onose; Aurelia Romila
Journal:  Exp Ther Med       Date:  2022-06-07       Impact factor: 2.751

Review 2.  The Impact of SARS-CoV-2 Infection on Youth Mental Health: A Narrative Review.

Authors:  Claudio Brasso; Silvio Bellino; Cecilia Blua; Paola Bozzatello; Paola Rocca
Journal:  Biomedicines       Date:  2022-03-25

3.  Dynamic Changes in Central and Peripheral Neuro-Injury vs. Neuroprotective Serum Markers in COVID-19 Are Modulated by Different Types of Anti-Viral Treatments but Do Not Affect the Incidence of Late and Early Strokes.

Authors:  Krzysztof Laudanski; Jihane Hajj; Mariana Restrepo; Kumal Siddiq; Tony Okeke; Daniel J Rader
Journal:  Biomedicines       Date:  2021-11-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.